Gabapentin Tablet
Product Images NDC 72162-1531

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph showing mean pain scores over 8 weeks comparing placebo to Gabapentin at 3600 mg/day. The x-axis indicates weeks including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with Gabapentin demonstrating a greater reduction in pain score compared to placebo over time.*

FDA Label Image

Figure 2 (Image 02)

A line graph comparing mean pain scores over seven weeks among three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The graph shows a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more for gabapentin groups compared to placebo.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows 12% for placebo and 29% for GBP 3600. Study 2 shows 14% for placebo and 32% and 34% for GBP 1800 and GBP 2400, respectively. Statistical significance is indicated with p-values < 0.01 and < 0.001.*

FDA Label Image

Image-04 (Image 04)

An illustration showing the formula for calculating creatinine clearance (CLCr). The formula includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, and a factor of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure diagram showing a hexagonal ring and attached amino and carboxyl groups, representing the active ingredient gabapentin.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart depicting the difference in percentage on the vertical axis and daily dose in milligrams on the horizontal axis. The chart compares three studies, labeled Study a, Study b, and Study c, showing their respective data points at daily doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Label (Lbl721621531)

Label for Gabapentin Tablets, USP 800 mg oral tablets, relabeled by Bryant Ranch Prepack and manufactured by ScieGen Pharmaceuticals. The label includes storage instructions, a quantity of 100 tablets, NDC 72162-1531-1, and a reminder to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.